In re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456; City of New York v. Abbott Laboratories, No. 01-cv-12257 (D. Mass. 2010). KM represented the State of Iowa, the City of New York, and forty-two New York State counties in a lawsuit against forty defendant drug manufacturers asserting that they manipulated their average wholesale price data to inflate prices charged to government drug benefits payers. Recovery of over $225 million for the plaintiffs.
Healthcare Fraud
Overview
Every year, state and local governments, corporations, unions, and other organizations that provide and pay for healthcare lose millions if not billions of dollars as a result of fraudulently inflated prescription drug and other health-related expenses. The risk to public and private payors of losing substantial sums of money as a result of healthcare fraud is real, and all entities that incur healthcare-related costs need to take an active role in protecting themselves.
In the healthcare industry, corporate misconduct takes myriad forms. Such risks include pharmaceutical manufacturers committing antitrust violations, improperly marketing their products, and failing to disclose the risks associated with their products or manipulating their drug prices, coupled with the difficulty of managing prescription drug benefit plans and relationships with pharmacy benefit managers and third party administrators.
Kirby McInerney provides the experience and dedication that our clients need to actively protect their interests in this arena. By taking legal action against corporations that attempt to profit at the expense of payors by engaging in illegal market manipulation, we help our clients to effectively ameliorate the financial risks posed to them by the possibility of healthcare fraud.
In the healthcare industry, corporate misconduct takes myriad forms. Such risks include pharmaceutical manufacturers committing antitrust violations, improperly marketing their products, and failing to disclose the risks associated with their products or manipulating their drug prices, coupled with the difficulty of managing prescription drug benefit plans and relationships with pharmacy benefit managers and third party administrators.
Kirby McInerney provides the experience and dedication that our clients need to actively protect their interests in this arena. By taking legal action against corporations that attempt to profit at the expense of payors by engaging in illegal market manipulation, we help our clients to effectively ameliorate the financial risks posed to them by the possibility of healthcare fraud.
Contacts
Featured Case
